Frontiers journals are at the top of citation and impact metrics
The Cardio-Oncology section of Frontiers in Cardiovascular Medicine is to provide a prime publication platform for this emerging field in medicine. It should speak to clinicians and researchers across the multiple diciplines that contribute to this field, including cardiology, oncology, hematology, radiation oncology, surgery, internal medicine, pediatrics, palliative care and geriatrics. It is a primary intent of this section to cultivate communication across these disciplines and along the scopes of clinical, basic and translational sciences.
The Cardio-Oncology section of Frontiers in Cardiovascular Medicine welcomes original articles, reviews, perspectives, case reports and other article types to choose from. Furthermore, this section welcomes clinical trial updates, including initial observations made in phase I and II cancer trials, and articles on the design of clinical trials in cardio-oncology. The Cardio-Oncology section also provides coverage of key meetings relevant to the field as well as a fellows corner and practice updates, including practice consensus and guideline documents. State-of-the-art reviews are accepted but will also be commissioned as will be viewpoints and debates (pros and cons topics). Certain topics may be highlighted in thematic collections (Research Topics).
The Cardio-Oncology section of Frontiers in Cardiovascular Medicine will cover the full and broad scope of cardio-oncology. The topics of interest include cardiovascular toxicities of cancer therapeutics including cardiomyopathy, heart failure, coronary artery disease, valvular heart disease, arrhythmias and device management, hypertension and renal disease, radiation-induced cardiovascular disease and side effects, multimodality imaging and biomarker use in cancer patients, genomics, proteomics, and metabolomics research in cardio-oncology, clinical trials in cardio-oncology, cardiovascular observations in cancer trials, including phase I and II trials on new cancer therapeutics, preclinial disease models, basic science and mechanisms of cardiovascular toxicities and their prevention.
Cardio-oncologists have to walk a thin line between harm and benefits of cancer treatments. Our goal is to provide a forum that covers the entire emerging interface between cardiovascular medicine and oncology and to inspire and inform the readers to stay most current and engaged in the field of cardio-oncology.
Indexed in: PubMed, PubMed Central, Google Scholar, DOAJ, CrossRef, Semantic Scholar, Ulrich's Periodicals Directory, ESCI, CLOCKSS
PMCID: all published articles receive a PMCID
Cardio-Oncology welcomes submissions of the following article types: Addendum, Case Report, Clinical Study Protocol, Clinical Trial, Correction, Curriculum, Instruction, and Pedagogy, Editorial, Erratum, General Commentary, Hypothesis and Theory, Mini Review, Opinion, Original Research, Perspective, Policy and Practice Reviews, Protocols, Review, Specialty Grand Challenge, Systematic Review and Technology Report.
All manuscripts must be submitted directly to the section Cardio-Oncology, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Cardio-Oncology will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Cardiovascular Medicine.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact firstname.lastname@example.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact email@example.com